000			02038 a2200625 4500
005			20250517053606.0
264		0	_c20160830
008			201608s 0 0 eng d
022			_a1949-2553
024	7		_a10.18632/oncotarget.5197 _2doi
040			_aNLM _beng _cNLM
100	1		_aFaloppi, Luca
245	0	0	_aThe value of lactate dehydrogenase serum levels as a prognostic and predictive factor for advanced pancreatic cancer patients receiving sorafenib. _h[electronic resource]
260			_bOncotarget _cOct 2015
300			_a35087-94 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aBiomarkers, Tumor _xblood
650	0	4	_aDisease-Free Survival
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aL-Lactate Dehydrogenase _xblood
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNiacinamide _xanalogs & derivatives
650	0	4	_aPancreatic Neoplasms _xblood
650	0	4	_aPhenylurea Compounds _xtherapeutic use
650	0	4	_aPrognosis
650	0	4	_aSorafenib
700	1		_aBianconi, Maristella
700	1		_aGiampieri, Riccardo
700	1		_aSobrero, Alberto
700	1		_aLabianca, Roberto
700	1		_aFerrari, Daris
700	1		_aBarni, Sandro
700	1		_aAitini, Enrico
700	1		_aZaniboni, Alberto
700	1		_aBoni, Corrado
700	1		_aCaprioni, Francesco
700	1		_aMosconi, Stefania
700	1		_aFanello, Silvia
700	1		_aBerardi, Rossana
700	1		_aBittoni, Alessandro
700	1		_aAndrikou, Kalliopi
700	1		_aCinquini, Michela
700	1		_aTorri, Valter
700	1		_aScartozzi, Mario
700	1		_aCascinu, Stefano
773	0		_tOncotarget _gvol. 6 _gno. 33 _gp. 35087-94
856	4	0	_uhttps://doi.org/10.18632/oncotarget.5197 _zAvailable from publisher's website
999			_c25287004 _d25287004